1st Circuit Denies Rehearing In Securities Suit Against Drug Company
BOSTON — The First Circuit U.S. Court of Appeals denied a petition for rehearing and rehearing en banc in a securities class action filed by a pharmaceutical company’s shareholders who alleged...To view the full article, register now.
Already a subscriber? Click here to view full article